Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. Aug. 3, 2018. Laurence Klotz.

Executive Summary

The University of Toronto's Laurence Klotz believes it will take a generation for the medical community to demonstrate that it's made progress in combating prostate cancer because it grows slowly. See what he said here.

"There are a lot of competing technologies and they really haven't been compared at all. It's going to take 20 years to sort out this story of partial gland ablation, because prostate is slow-growing. It takes a long time to demonstrate that you've made a difference." –Laurence Klotz, interventional urologist and professor of surgery, University of Toronto

Click here for a free trial of Medtech Insight


Related Content

Market Intel: New Thermal Therapies Blaze Trail In Fast-Growing Cancer Ablation Market





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts